Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis

  • Lucy Kappes
  • , Ruba L. Amer
  • , Sabine Sommerlatte
  • , Ghada Bashir
  • , Corinna Plattfaut
  • , Frank Gieseler
  • , Timo Gemoll
  • , Hauke Busch
  • , Abeer Altahrawi
  • , Ashraf Al-Sbiei
  • , Shoja M. Haneefa
  • , Kholoud Arafat
  • , Lena F. Schimke
  • , Nadia El Khawanky
  • , Kai Schulze-Forster
  • , Harald Heidecke
  • , Anja Kerstein-Staehle
  • , Gabriele Marschner
  • , Silke Pitann
  • , Hans D. Ochs
    • Antje Mueller, Samir Attoub, Maria J. Fernandez-Cabezudo, Gabriela Riemekasten, Basel K. al-Ramadi, Otavio Cabral-Marques

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science